Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Goldenberg

Showing results (241-250 of 1,192) with videos related to

Pageof 120
Sort By:
Cancer Research|February 4, 2010
Surface charge: a key determinant of protein localization and functionNeil M Goldenberg, Benjamin E Steinberg
Diabetes Care|May 15, 2023
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390Ronald M Goldenberg, Akshay B Jain
Thescientificworldjournal|October 19, 2010
New antibody conjugates in cancer therapySerengulam V Govindan, David M Goldenberg
Hospital Practice (1995)|October 5, 2010
Radioactive antibodies: a historical review of selective targeting and treatment of cancerDavid M Goldenberg, Robert M Sharkey
Immunotherapy|March 15, 2011
Cancer radioimmunotherapyRobert M Sharkey, David M Goldenberg
CA: a Cancer Journal for Clinicians|July 28, 2006
Targeted therapy of cancer: new prospects for antibodies and immunoconjugatesRobert M Sharkey, David M Goldenberg
Cancer Investigation|February 10, 2006
Advances in radioimmunotherapy in the age of molecular engineering and pretargetingRobert M Sharkey, David M Goldenberg
The Urologic Clinics of North America|May 1, 1984
Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphataseD M Goldenberg, F H DeLand
Archives Internationales De Pharmacodynamie Et De Therapie|July 1, 1977
Anti-inflammatory activity of EU-2972, 2-(3,4-dichlorphenylamino)quinolizinium bromideM M Goldenberg, A C Ilse
Surgical Neurology|February 1, 1994
Usefulness of a fiber optic Swan-Ganz catheter to monitor oxygen transport during volume expansion in a patient with ischemic neurologic deficits from aneurysmal subarachnoid hemorrhageM B Pritz, T M Goldenberg
Pageof 120

Showing results (241-250 of 1,192) with videos related to

Sort By:
Pageof 120
Cancer Research|February 4, 2010
Surface charge: a key determinant of protein localization and functionNeil M Goldenberg, Benjamin E Steinberg
Diabetes Care|May 15, 2023
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390Ronald M Goldenberg, Akshay B Jain
Thescientificworldjournal|October 19, 2010
New antibody conjugates in cancer therapySerengulam V Govindan, David M Goldenberg
Hospital Practice (1995)|October 5, 2010
Radioactive antibodies: a historical review of selective targeting and treatment of cancerDavid M Goldenberg, Robert M Sharkey
Immunotherapy|March 15, 2011
Cancer radioimmunotherapyRobert M Sharkey, David M Goldenberg
CA: a Cancer Journal for Clinicians|July 28, 2006
Targeted therapy of cancer: new prospects for antibodies and immunoconjugatesRobert M Sharkey, David M Goldenberg
Cancer Investigation|February 10, 2006
Advances in radioimmunotherapy in the age of molecular engineering and pretargetingRobert M Sharkey, David M Goldenberg
The Urologic Clinics of North America|May 1, 1984
Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphataseD M Goldenberg, F H DeLand
Archives Internationales De Pharmacodynamie Et De Therapie|July 1, 1977
Anti-inflammatory activity of EU-2972, 2-(3,4-dichlorphenylamino)quinolizinium bromideM M Goldenberg, A C Ilse
Surgical Neurology|February 1, 1994
Usefulness of a fiber optic Swan-Ganz catheter to monitor oxygen transport during volume expansion in a patient with ischemic neurologic deficits from aneurysmal subarachnoid hemorrhageM B Pritz, T M Goldenberg
Pageof 120